Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

This Marijuana Stock Is On an 8-Day Losing Streak -- Is It Time to Buy?
This Marijuana Stock Is On an 8-Day Losing Streak -- Is It Time to Buy?
Over the trailing year, there's arguably been no better-performing industry than marijuana and marijuana stocks. A majority of pot stocks have moved significantly higher over the past year, with a....

	 
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
OFFRE PUBLIQUE D'ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIETE ALPHA MOS INITIEE CONJOINTEMENT PAR JOLT CAPITAL AMBROSIA INVESTMENTS PRESENTEE PAR ALANTRA COMMUNIQUE DE MISE....
Of the 14 Largest Marijuana Stocks, Only These 2 Are Down Over the Past Year
Of the 14 Largest Marijuana Stocks, Only These 2 Are Down Over the Past Year
The stock market has been on a tear since hitting a trough in March 2009, but in recent years it's marijuana stocks that have headed to the front of the class, so to speak. Back in June, we looked....

	 
ALPHA MOS : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2017
ALPHA MOS : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2017
Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) annonce, ce jour, avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés financiers (AMF)....

	 
ALPHA MOS : RESULTATS SEMESTRIELS 2017
ALPHA MOS : RESULTATS SEMESTRIELS 2017
Au cours de sa réunion du 11 septembre 2017, le Conseil d'administration d'Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) a arrêté les comptes semestriels 2017,....

	 
ALPHA MOS : MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 29 SEPTEMBRE 2017
ALPHA MOS : MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 29 SEPTEMBRE 2017
Les actionnaires de la société Alpha MOS sont invités à participer à une assemblée générale mixte qui se tiendra le 29 septembre 2017 à 10 heures. Au siège social de la société : Immeuble Le....
Why This Marijuana Stock Crashed 18.5% in August
Why This Marijuana Stock Crashed 18.5% in August
Arizona's attorney general is suing Insys Therapeutics (NASDAQ: INSY) over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company's shares to tumble 18.5% in August,....
94% of Americans Support Legalizing Medical Marijuana, but Not Congress
94% of Americans Support Legalizing Medical Marijuana, but Not Congress
When it comes to the fastest, most consistently growing industries in the U.S. right now, legal marijuana is near the top of the list. Investment firm Cowen & Co. has predicted that U.S. legal....

	 
ALPHA MOS : Communiqué normé - Cible
ALPHA MOS : Communiqué normé - Cible
COMMUNIQUE RELATIF AU DEPOT D'UN PROJET DE NOTE EN REPONSE A L'OFFRE PUBLIQUE D'ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIETE Alpha MOS INITIEE CONJOINTEMENT PAR Jolt capital Ambrosia....
3 Top Healthcare Stocks to Buy Now
3 Top Healthcare Stocks to Buy Now
It's been a good year for healthcare stocks in general, but a handful of quality companies haven't been swept upward with the rest of the sector. Allergan plc (NYSE: AGN) and CVS Health Corp.....
3 Top Biotech Stocks Under $10
3 Top Biotech Stocks Under $10
Cheap and junk don't have to go hand in hand. Sometimes, items that are inexpensive could still have tremendous potential for their values to increase. That can be true with anything you buy --....
3 Game-Changing Small-Cap Healthcare Stocks
3 Game-Changing Small-Cap Healthcare Stocks
The ability to shake up patient treatment could mean big bucks for Tetraphase Pharmaceuticals (NASDAQ: TTPH), NovoCure (NASDAQ: NVCR), and Exact Sciences (NASDAQ: EXAS). Should you be buying shares in
3 Beaten-Up Biotech Stocks: Are They Bargains?
3 Beaten-Up Biotech Stocks: Are They Bargains?
The iShares Nasdaq Biotechnology Index has tacked on a healthy gain of around 15% so far this year, without any help from Celldex Therapeutics, Inc. (NASDAQ: CLDX), Agenus Inc. (NASDAQ: AGEN), or
This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug
This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug
If you look around, chances are you won't find many marijuana stocks struggling. In fact, over the trailing one-year period, 12 out of 13 pot stocks with a market cap above $200 million had risen
3 Marijuana Stocks That Could Make You the Most Money in the 2nd Half of 2017
3 Marijuana Stocks That Could Make You the Most Money in the 2nd Half of 2017
For investors who enjoyed the huge run of marijuana stocks last year, the first half of 2017 probably hasn't been as exciting. Several of the largest marijuana stocks haven't performed all that great
This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged
This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged
When it comes to the market's top-performing stocks, you'd have a hard time topping marijuana stocks over the trailing year. A majority of pot stocks over the past 12 months have at least doubled in

	 
ALPHA MOS : Informations relatives au nombre total de droits de vote
ALPHA MOS : Informations relatives au nombre total de droits de vote
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Why Tetraphase Pharmaceuticals Fell 11.7% Today
Why Tetraphase Pharmaceuticals Fell 11.7% Today
After reporting positive trial results for its lead product candidate on July 25, Tetraphase Pharmaceuticals (NASDAQ: TTPH) announced a $60 million share offering today that will dilute investors, and
Here's Why Tetraphase Pharmaceuticals Rose as Much as 26.8% Today
Here's Why Tetraphase Pharmaceuticals Rose as Much as 26.8% Today
Shares of clinical-stage biopharma Tetraphase Pharmaceuticals (NASDAQ: TTPH) soared nearly 27% today after the company announced positive top-line results for a phase 3 trial evaluating its lead

	 
ALPHA MOS : Chiffre d'affaires du 1er semestre 2017
ALPHA MOS : Chiffre d'affaires du 1er semestre 2017
En M€ - Normes IFRS Données non auditées 2017 2016 Variation Chiffre d'affaires consolidé 2,1 3,8 -44% Alpha MOS (Euronext Paris - Compartiment C - Code ISIN....
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics
Celldex Therapeutics (NASDAQ: CLDX) and Juno Therapeutics (NASDAQ: JUNO) are both once-promising clinical-stage biotechs that have fallen on extremely hard times of late. Over the past two and half
5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals
5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals
There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there's the third type of marijuana stock: the

	 
ALPHA MOS : Acquisition d'une participation de contrôle dans la société Alpha MOS par Jolt Capital et Ambrosia Investments et intention de dépôt d'un projet d'offre publique d'achat simplifiée
ALPHA MOS : Acquisition d'une participation de contrôle dans la société Alpha MOS par Jolt Capital et Ambrosia Investments et intention de dépôt d'un projet d'offre publique d'achat simplifiée
Jolt Capital et Ambrosia Investments ont procédé le 26 juin 2017 à l'acquisition de la participation détenue par la société Diagnostic Medical Systems (DMS) dans la société Alpha Mos,....

	 
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES FINANCIERS
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES FINANCIERS
Date Nombre d'actions Nombre total de droits de vote 31/05/2017 33 485 474 Droits de vote théoriques 41 613 659 Droits de vote exerçables 41 581....

	 
ALPHA M.O.S : CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2017
ALPHA M.O.S : CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2017
En M€ - Normes IFRS Données non auditées 2017 2016 Variation Chiffre d'affaires consolidé 1,0 1,8  -46%   Alpha MOS (Euronext Paris – Compartiment C – Code ISIN :....